US Drug Importation: Hard To See Path Forward, Former HHS Adviser Says

 
• By Cathy Kelly

Former drug pricing advisor John O’Brien discusses next steps for Administration policies around importation and international reference pricing during a speech to the Academy of Managed Care Pharmacy.

Top view of a caucasian businessman lost in a maze - Image
Too Many Obstacles In The Way For Drug Importation?

More from Pricing Debate

More from Market Access